Skip to main content
. 2021 May 24;11(6):462. doi: 10.3390/jpm11060462

Table 1.

Demographic details of the patients (n = 74) included in this series.

Data Patients (n) %
Age (mean years) 46 (range, 9–88) -
Gender (male/female) 37/37 -
Obesity 16 21.6
Hypertension 15 20.3
Smoking 13 17.6
Dyslipidemia 6 8.1
Type II diabetes 4 5.4
Peripheral arterial disease 4 5.4
Coronary artery disease 1 1.4
Previous deep vein thrombosis 3 4.1
>1 cardiovascular risk factors 45 60.8
American Society of Anesthesiologists (ASA) Score 1 14 18.9
American Society of Anesthesiologists (ASA) Score 2 45 60.8
American Society of Anesthesiologists (ASA) Score 3 15 20.3
Bone tumors 54 73
 Symptoms:
  Pain 38 70.4
  Swelling 8 14.8
  Functional limitation 9 16.7
  Pathological fracture 7 13
  Asymptomatic 9 16.7
 Histological diagnosis:
  Osteosarcoma 19 35.1
  Chondrosarcoma 16 29.6
  Ewing’s sarcoma 3 5.6
  Chordoma 1 1.9
  Metastatic bone disease 11 20.4
  Hematological malignancies 4 7.4
 Site:
  Proximal tibia 15 27.8
  Proximal femur 12 22.2
  Pelvis/sacrum 9 16.7
  Distal femur 9 16.7
  Proximal humerus 6 11.1
  Scapula 1 1.9
  Humeral shaft 1 1.9
  Proximal tibia/distal tibia 1 1.9
Soft tissue tumors 20 27
 Symptoms:
  Mass/Swelling 13 65
  Pain 8 40
  Functional limitation 2 10
  Asymptomatic 3 15
 Histological diagnosis:
  Synovial sarcoma 7 35
  Leiomyosarcoma 2 10
  Liposarcoma 2 10
  Pleomorphic sarcoma 2 10
  Other 7 35
 Site:
  Thigh 9 45
  Popliteal fossa 3 15
  Hip 2 10
  Buttocks 2 10
  Forearm 2 10
  Knee 1 5
  Pelvis 1 5
Metastases at time of surgery (bone and soft tissue tumors) 10 13.5
  Lung metastases: 9 12.2
  Skip metastases 1 1.4